HER-2/neu gene analysis on endoscopic biopsy samples and gastric resection materials in gastric carcinomas

HER-2/neu gene analysis on endoscopic biopsy samples and gastric resection materials in gastric carcinomas

Objective ― HER-2/neu assay in gastric cancers is routinely evaluated by immunohistochemistry and fluorescent in situ hybridization methods because the monoclonal antibody trastuzumab developed against HER-2/neu give rise to significant improving on the survival. In the HER-2/neu evaluation, some pr...

Full description

Bibliographic Details
Main Authors:	Ali Zisan Genc, Resit Dogan Koseoglu, Akgul Arici, Osman Demir
Format:	Article
Language:	English
Published:	Limited liability company «Science and Innovations» (Saratov) 2019-12-01
Series:	Russian Open Medical Journal
Subjects:	immunohistochemistry her-2/neu gastric adenocarcinoma endoscopic biopsy in situ hybridization
Online Access:	http://www.romj.org/node/288

Similar Items

Role of HER2neu expression in gastric cancer
by: J S Sukanya, et al.
Published: (2021-01-01)

Prevalence of Her2-neu status and its clinicopathological association in newly diagnosed gastric cancer patients
by: Joseph Kattan, et al.
Published: (2022-11-01)

HER-2/Neu and Hormone Receptor Analysis in Breast Carcinomas and Their Association with Clinicopathologic Parameters
by: Reşit Doğan Köseoğlu, et al.
Published: (2019-01-01)

Inter-observer agreement in reporting HER 2 Neu protein over expression by immunohistochemistry
by: Ibrahim Al Haddabi, et al.
Published: (2014-01-01)

HER-2/neu over expression in gall bladder adenocarcinoma: A quest for potential therapeutic target
by: Pragya Jain, et al.
Published: (2020-01-01)

HER2 and Helicobacter pylori Status in Resected Gastric Cancers: A Pathological Study of a Gastroenterological Issue
by: Saraswathy Sreeram, et al.
Published: (2017-10-01)

Study of human epidermal growth factor receptor (HER2/neu) expression in primary colorectal carcinoma in a tertiary care hospital
by: Mousmi Agrawal, et al.
Published: (2021-01-01)

Prognostic value of immunohistochemical marker HER2/neu in patients resected for gastric cancer stage IIIA
by: O. M. Levyk
Published: (2014-04-01)

Her2neu Expression of Gastric and Lower Esophageal Carcinoma and its Correlation with Clinicopathological Findings in Tertiary Care Hospital in Eastern India
by: Dipsikha Chakraborty, et al.
Published: (2022-01-01)

Clinicopathological Significance and Prognostic Role of Her2neu Protein Expression in Patients with Carcinoma Stomach: A Prospective Study from Northern India
by: Abhilash V. B., et al.
Published: (2023-04-01)

HER 2 Expression in Gastric and Gastro-esophageal Junction (GEJ) Adenocarcinomas
by: Indu Rajagopal, et al.
Published: (2015-03-01)

Clinical and prognostic profile of Her2neu positive (non-luminal) intrinsic breast cancer subtype: comparison with Her2neu positive luminal breast cancers
by: Atif Ali Hashmi, et al.
Published: (2018-08-01)

Prognosis significance of HER-2/neu overexpression/amplification in Chinese patients with curatively resected gastric cancer after the ToGA clinical trial
by: Zhou Fei, et al.
Published: (2012-12-01)

Gastric adenocarcinoma expressing human epidermal growth factor receptor in South Asian population
by: Asma Shabbir, et al.
Published: (2018-01-01)

HER-2/neu overexpression in breast cancer
by: Rana S. Aziz, et al.
Published: (2010-10-01)

Expression of Her-2/neu in extrahepatic cholangiocarcinoma
by: Shamekh R, et al.
Published: (2017-02-01)

Study of gastrointestinal neoplasms, histopathologic and immunohistochemical correlation using HER-2/NEU, CK-7 and CK-20
by: Pramod Kumar Reddy M, et al.
Published: (2023-07-01)

Her-2 neu (Cerb-B2) expression in fine needle aspiration samples of breast carcinoma: A pilot study comparing FISH, CISH and immunocytochemistry
by: Kusum Kapila, et al.
Published: (2011-01-01)

Incorporation of p-53 mutation status and Ki-67 proliferating index in classifying Her2-neu positive gastric adenocarcinoma
by: Ayesha Ahmed, et al.
Published: (2018-01-01)

Molecular Targeting of Her-2/neu Protein Is Not Recommended as an Adjuvant Therapy in Oral Squamous Cell Carcinoma and Oral Lichen Planus
by: Maryam Kouhsoltani, et al.
Published: (2015-12-01)

HER 2 status in invasive breast cancer: Immunohistochemistry, fluorescence in-situ hybridization and chromogenic in-situ hybridization
by: Hemlata S Shirsat, et al.
Published: (2012-01-01)

Association between HER-2/Neu overexpression in gastric adenocarcinoma and histopathologic features of tumor in gastrectomy samples: a cross-sectional study in Kerman, Iran
by: Mohammad Mahdi Hayatbakhsh Abbasi, et al.
Published: (2019-05-01)

Expression of Her2-Neu in Primary Gastric and Gastroesophageal Adenocarcinoma: An Experience from a Tertiary Center in South India
by: Aditi Damle, et al.

Immunohistochemical expression of HER2/neu in colorectal carcinoma in Erbil city, Kurdistan Region
by: Lilav Adel Kamal, et al.
Published: (2019-12-01)

Quantitative real-time PCR assay with immunohistochemical evaluation of HER2/neu oncogene in breast cancer patients and its correlation with clinicopathological findings
by: Nadia Gheni, et al.
Published: (2020-01-01)

HER2/neu Oncogene and Sensitivity to the DNA-Interactive Drug Doxorubicin
by: Anne Mullin, et al.
Published: (2020-12-01)

Complicating pericarditis and cardiac tamponade in a patient of primary HER2/neu positive gastric signet ring cell carcinoma
by: Yu-Guang Chen, et al.
Published: (2017-06-01)

Physical basis of the ‘magnification rule’ for standardized Immunohistochemical scoring of HER2 in breast and gastric cancer
by: Andreas H. Scheel, et al.
Published: (2018-03-01)

A Study of Epidermal Growth Factor Receptor 2 (HER2/neu) Expression in Endoscopic Biopsies and Gastrectomy Specimens of Gastric Adenocarcinomas
by: Sheela Devi CS, et al.
Published: (2016-10-01)

Estudo comparativo entre os métodos LSAB®+ e Herceptest® para a detecção de HER-2/neu em carcinoma de mama A comparative study between LSAB®+ and Herceptest® in the detection of HER-2/neu in breast carcinoma
by: Alexandre de Oliveira Sales, et al.
Published: (2004-08-01)

Combined Expression of HGFR with Her2/neu, EGFR, IGF1R, Mucin-1 and Integrin α2β1 Is Associated with Aggressive Epithelial Ovarian Cancer
by: Bastian Czogalla, et al.
Published: (2022-10-01)

Role of p53 and Her2/Neu as a prognostic biomarker in breast carcinoma
by: Anamika Gupta, et al.
Published: (2023-01-01)

cERBB-2/Her-2 Neu Overexpression and Prognostic Significance in Uterine Carcinosarcoma
by: Huseyin Salih SEMIZ, et al.
Published: (2023-01-01)

Applicability and interpretation of HER2/Neu & PD-L1 stains in gastrointestinal tract tumours
by: Prasenjit Das, et al.
Published: (2021-01-01)

Concordance of HER2 status tested by IHC and FISH in biopsy and surgical resection specimens and comparison with clinicopathological features in gastric carcinoma
by: Döndü Nergiz, et al.
Published: (2022-01-01)

HER-2/neu expression in lesions of uterine cervix: Is it reliable and consistent?
by: Gupta Nidhi, et al.
Published: (2009-10-01)

Peripheral position of CCND1 and HER-2/neu oncogenes within chromosome territories in esophageal and gastric cancers non-related to amplification and overexpression
by: Lucimari Bizari, et al.
Published: (2009-01-01)

Silencing of the HER2/neu Gene by siRNA Inhibits Proliferation and Induces Apoptosis in HER2/neu-Overexpressing Breast Cancer Cells
by: Timo Faltus, et al.
Published: (2004-11-01)

Correlation of histological grade with Estrogen, Progesterone and HER2/neu reactivity in breast cancer
by: Girishma Shrestha, et al.
Published: (2019-09-01)

HER-2/NEU Ekspresyonun Saptanmasinda İmmunohistokimyasal ve Fish Yöntemi Arasında Diskordansin Belirlenmesi Önemli midir?
by: Berna Bozkurt DUMAN, et al.
Published: (2014-07-01)